MedPath

Meiziya Kang L11 Capsules

Registration Number: MAL22056061TC

Approved
Approval ID

11e9e4a5b6fe783b

Registration Number

MAL22056061TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

28 CapsulesAvailable
Package Size: 28 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

Lycium barbarumActive
Monograph: lycium barbarum
Glehnia littoralisActive
Monograph: glehnia littoralis
Ziziphus jujubaActive
Monograph: ziziphus jujuba
Anemarrhena asphodeloidesActive
Rehmannia GlutinosaActive
Ophiopogon japonicusActive
Monograph: ophiopogon japonicus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meiziya Kang L11 Capsules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform